Bovine milk ‘whey protein concentrate containing milk fat globule membrane’ (WPC MFGM): Determination of the status of a novel food, pursuant to Article 4(2) of assimilated Regulation (EU) 2015/2283
Published 26 June 2026
Applies to England and Wales
© Crown copyright 2026
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/bovine-milk-whey-protein-concentrate-containing-milk-fat-globule-membrane-wpc-mfgm-determination-of-the-status-of-a-novel-food-pursuant-to-article-42-/bovine-milk-whey-protein-concentrate-containing-milk-fat-globule-membrane-wpc-mfgm-determination-of-the-status-of-a-novel-food-pursuant-to-artic
UK Regulated Product (RP) number: 2319
1. Name and description of the food concerned
Bovine milk ‘whey protein concentrate containing milk fat globule membrane (WPC MFGM)’ produced from whey and containing 71% protein and 19% fat in the final ingredient (this is not a labelling designation).
2. Definition of novel food
Article 3(2)(a) of assimilated Regulation (EU) 2015/2283 defines ‘novel food’ as any food that was not used for human consumption to a significant degree within the European Union or the United Kingdom (UK) before 15 May 1997, irrespective of the dates of accession of Member States, and which falls into one of the categories at (i) to (x) of that provision.
3. Status
The Food Standards Agency (FSA) determines that bovine milk ‘whey protein concentrate containing milk fat globule membrane (WPC MFGM) is not a novel food.
4. Reasons statement
The FSA was provided with evidence of a history of consumption applicable to bovine milk ‘whey protein concentrate containing milk fat globule membrane’ (WPC MFGM) within the UK and the EU. The product is produced using physical filtration techniques commonly used in the dairy industry.
The evidence, considered in its totality, was deemed sufficient to demonstrate a significant history of consumption.
Based on the evidence provided, the FSA has concluded that bovine milk ‘whey protein concentrate containing milk fat globule membrane’ (WPC MFGM) is therefore not novel.
This decision will be published on the FSA website and is applicable in England and Wales. Food Standards Scotland (FSS) will issue their own determination applicable in Scotland.